XB
Xenagos Bio, Inc.
SEC filingBiotechnology · Philadelphia, PA
Amount raised$2.5Msold at filing
Total offering$2.5M
Investors in the raise23count reported to the SEC
FiledMay 15, 2026first sale Apr 30, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Abel J. De La RosaDirector
Michael J. McElhaughExecutive Officer, Director
Patrick J. HigginsDirector
Executive officers, directors and promoters as listed on the Form D.